Artificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients?

dc.authorid0000-0003-0205-5075
dc.authorid0009-0002-1037-5167
dc.authorid0000-0002-8458-3535
dc.authorid0000-0001-6730-9932
dc.authorid0000-0002-5050-5694
dc.authorid0000-0002-5180-9649
dc.contributor.authorŞenel, Merve Yumrukuz
dc.contributor.authorAyan, Emine
dc.contributor.authorÇolak, Mustafa
dc.contributor.authorÇoban, Hikmet
dc.contributor.authorErel, Fuat
dc.contributor.authorSarıoğlu, Nurhan
dc.date.accessioned2026-05-21T08:15:11Z
dc.date.issued2026
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractOBJECTIVE: The aim of this study was to determine the quality, reliability, and readability of the responses provided by artificial intelligence chatbots about idiopathic pulmonary fibrosis. METHODS: The clinically relevant questions about idiopathic pulmonary fibrosis diagnosis, treatment, prognosis, and lifestyle management were submitted to four widely used artificial intelligence chatbots, including ChatGPT, Perplexity, Gemini, and Copilot. Responses were assessed by five clinicians based on readability, understandability, quality, and content reliability using standardized tools. RESULTS: The overall readability of chatbot-generated responses was low, corresponding to high educational requirements. Understandability ranged from moderate to good, whereas actionability remained moderate. Gemini produced the most readable and understandable outputs. Journal of the American Medical Association and Likert scores indicated limited source transparency but good guideline concordance. DISCERN analysis for the treatment question showed significant variation (p=0.003), with Perplexity achieving the highest total score. CONCLUSION: Although artificial intelligence chatbots offer rapid and accessible information, their readability and source reliability remain limited. These findings highlight the necessity of expert supervision and further model improvement before artificial intelligence chatbots can be safely integrated into patient education.
dc.identifier.doi10.1590/1806-9282.20251080
dc.identifier.endpage6
dc.identifier.issn0104-4230
dc.identifier.issue2
dc.identifier.pmid42018843
dc.identifier.scopus2-s2.0-105036607979
dc.identifier.scopusqualityQ2
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.1590/1806-9282.20251080
dc.identifier.urihttps://hdl.handle.net/20.500.12462/23974
dc.identifier.volume72
dc.identifier.wosWOS:001752634600001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAssociacao Medica Brasileira
dc.relation.ispartofRevista da Associacao Medica Brasileira
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectArtificial Intelligence
dc.subjectChatbots
dc.subjectIdiopathic Pulmonary Fibrosis
dc.subjectInform
dc.subjectTreatment
dc.titleArtificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients?
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
m-senel.pdf
Boyut:
192.47 KB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: